Adverse events reported in kigs

Growth Hormone Therapy in Pediatrics-20 Years of KIGS

Volumn , Issue , 2007, Pages 432-441

  Wilton, Patrick ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 51949116012     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1159/000101934     Document Type: Chapter

References (55)

1. Hintz LR: Untoward events in patients treated with growth hormone in the USA. Horm Res 1992; 38: 44-49.
2. Job JC, Maillard F, Goujard J: Epidemiologic survey of patients treated with growth hormone in France in the period 1959-1990: preliminary results. Horm Res 1992; 38: 35-43.
3. World Health Organization Collaborating Centre for International Drug Monitoring: International Monitoring of Adverse Reactions to Drugs: Adverse Reaction Terminology. Uppsala, World Health Organization, 1992.
4. World Health Organization: Manual of the International Statistical Classification of Diseases, Injuries and Causes of Death, ed 9. Geneva, World Health Organization, 1978.
5. Endo K, Kaneko Y, Shikano T, Minami H, Chino J: Possible association of human growth hormone treatment with an occurrence of acute myeloblastic leukaemia with an incision of chromosome in a child of pituitary dwarfism. Med Pediatr Oncol 1988; 16: 45-47.
6. Stahnke N: Leukaemia in growth hormone- treated patients: an update, 1992. Horm Res 1992; 38: 56-62.
7. Underwood L: The risks of growth hormone therapy: does growth hormone influence tumour formation or tumour growth?; in Frish H, Thomer M (eds): Hormonal Regulation of Growth (Serono Symposium). New York, Raven, 1998, p 58
8. Rappaport R, Oberfield SE, Robison L, Salisbury S, David R, Rao J, Redmond GP: Relationship of growth hormone deficiency and leukaemia. J Pediatr 1995; 126: 759-761.
9. Watanabe S, Mizuno S, Tsunematsu Y, Komlyamu A, Fuji K, Kubota M: Leukaemia in GH-deficient children. Clin Pediatr Endocrinol 1994; 3(suppl 5):53- 60.
10. Nishi Y, Tanaka T, Takano K, Fujieda K, Igarashi Y, Hanew K, Hirano T, Yokoya S, Tachibana K, Saito T, Watanabe S: Recent status in the occurrence of leukaemia in growth hormone-treated patients in Japan. GH Treatment Study Committee of the Foundation for Growth Science, Japan. J Clin Endocrinol Metab 1999; 84: 1961-1965.
11. Ogilvy-Stuart AL, Ryder WDJ, Gattamaneni HR, Clayton PE, Shalet SM: Growth hormone and tumour recurrence. BMJ 1992; 304: 601-605.
12. Rivera G, Pui CH, Hancock M, Mahmoud H, Santana V, Sandbend J, Hurwitz C, Ribeiro R, Furman W, Crist W: Update of St Jude study XI for childhood acute lymphoblastic leukemia. Leukemia 1992; 6(suppl 2):167-170.
13. Neglia JP, Meadows AT, Robison LL, Kim TH, Newton WA, Ruymann FB, Sather HN, Hammond GD: Second neoplasms after acute lymphoblastic leukemia in childhood. N Engl J Med 1991; 325: 1330-1336.
14. Nygaard R, Garwicz S, Haldorsen T, Hertz H, Johmundsson GK, Lanning M, Moe PJ: Second malignant neoplasms in patients treated for childhood leukemia. Acta Paediatr Scand 1991; 80: 1220-1228.
15. Sklar CA, Mertens AC, Mitby P, Occhiogrosso G, Qin J, Heller G, Yasui Y, Robinson LL: Risk of disease recurrence and second neoplasms in survivors of childhood cancer treated with growth hormone: a report from the childhood cancer survivor study. J Clin Endocrinol Metab 2002; 87: 3136-3141.
16. Ergun-Longmire B, Mertens A, Mitby P, Qin J, Heller G, Shi W, Yasui Y, Robinson L, Sklar C: Growth hormone treatment and risk of second neoplasms in the childhood cancer survivor. J Clin Endocrinol Metab 2006; 91: 3494-3498
17. Arslanian S, Becker D, Lee P, Drash L, Foley T: Growth hormone and tumour recurrence: findings in children with brain neoplasms and hypopituitarism. Am J Dis Child 1995; 139: 347-350.
18. Darendeliler F, Karagiannis G, Wilton P, Ranke MB, Albertsson-Wikland K, Price DA, on behalf of the KIGS International Board: Recurrence of brain tumours in patients treated with growth hormone: analysis of KIGS (Pfizer International Growth Database). Acta Paediatr 2006; 95: 1284- 1290.
19. Weiss M, Sutton L, Marcial V, Fowble B, Packer R, Zimmermann R, Schul L, Bruce D, D'Angio G: The role of radiation therapy in the management of childhood craniopharyngioma. Int J Radiat Oncol Biol Phys 1989; 17: 1313- 1321
20. Berry MP, Jenkin RDT, Keen CW, Nair BD, Simpson WJ: Radiation treatment for medulloblastoma: a 21-year review. J Neurosurg 1981; 55: 43-51.
21. Bloom HJG, Thornton H, Schweisguth O: SIOP medulloblastoma and highgrade ependymoma therapeutic clinical trial: preliminary results (1975- 1981); in Raybaud C, Clement R, Lebrueil G, Bernard JL (eds): Pediatric Oncology: Proceedings of the 13th Annual Meeting of the International Society of Pediatric Oncology, Marseilles, September 1981. Amsterdam, Excerpta Medica, 1981, pp 309-322.
22. Stiller C, Lennox E: Childhood medulloblastoma in Britain 1971-1977: analyses of treatment and survival. Br J Cancer 1983; 48: 835-841.
23. Duffner PK, Cohen ME, Myers MH, Heise HW: Survival of children with brain tumours: SEER program, 1973- 1980. Neurology 1986; 36: 597-601.
24. Swerdlow A, Reddingius R, Higgins C, Spoudeas H, Phipps K, Qiao Z, Ryder W, Brada M, Hayward R, Brook C, Hindmarsh P, Shalet S: Growth hormone treatment of children with brain tumours and risk of tumour recurrence. J Clin Endocrinol Metab 2000; 85: 4444-4449.
25. Ilgren EB, Stiller CA: Cerebellar astrocytomas: therapeutic management. Acta Neurochir 1986; 81: 11-26.
26. Rosenfeld R, Wilson D, Dollar L, Bennett A, Hintz R: Both human pituitary growth hormone and recombinant DNA-derived human growth hormone cause insulin resistance at a post-receptor level. J Clin Endocrinol Metab 1982; 54: 1033-1038.
27. Crawford BA, Cowell P, Greenacre NJ: Carbohydrate metabolism on highdose growth hormone therapy in children treated for leukaemia. Aust Paediatr J 1989; 25: 236-240.
28. Czernichow P, Albertsson-Wikland K, Tuvemo T, Gunnarsson R, on behalf of the International Board of KIGS: Growth hormone treatment and diabetes: survey of the Kabi Pharmacia International Growth Study. Acta Paediatr Scand Suppl 1991; 379: 104-107.
29. Gard AA, Jones R: Growth hormone therapy and hyperglycaemia. Saudi Med J 1990; 11: 328-329.
30. Botero D, Danon M, Rosalind SB: Symptomatic non-insulin-dependent diabetes mellitus during therapy with recombinant human growth hormone. J Pediatr 1993; 123: 590-592.
31. Shizume K: Long-term effects of human growth hormone on 1,959 patients with pituitary dwarfism throughout Japan. Endocrinol Jpn 1984; 31: 201- 206.
32. Kitagawa T, Owada M, Urakami T, Tajimu N: Epidemiology of type 1 (insulin- dependent) and type 2 (non-insulin- dependent) diabetes mellitus in Japanese children. Diabetes Res Clin Pract 1994; 24:S7-S13.
33. Pinhas-Maniel O, Dolan LM, Daniels SR, Standiford D, Khoury PR, Zeiller P: Increased incidence of non-insulindependent diabetes mellitus among adolescents. J Pediatr 1996; 128: 608- 615.
34. Otten BJ, Roittevel JJ, Cruysberg JRM: Pseudotumor cerebri following treatment with growth hormone (abstract). Horm Res 1992; 37: 16.
35. Malazowski S, Tanner L, Wysowski D, Fleming G: Growth hormone, insulinlike growth factor I and benign intracranial hypertension. N Engl J Med 1993; 329: 665-666.
36. Blethen SL, Allen DB, Graves D, August G, Moshang T, Rosenfeld R: Safety of recombinant deoxyribonucleic acidderived growth hormone: the National Cooperative Growth Study experience. J Clin Endocrinol Metab 1996; 81: 1704- 1710.
37. Crock PA, McKenzie JD, Nicoll AM, Howard NJ, Cutfield W, Shield LK, Byrne G: Benign intracranial hypertension and recombinant growth hormone therapy in Australia and New Zealand. Acta Paediatr 1998; 87: 381-386.
38. Henriksson B: The incidence of slipped capital femoral epiphysis. Acta Orthop Scand 1969; 40: 365-372.
39. Kelsey JL, Keggi KJ, Southwick WO: The incidence and distribution of slipped capital femoral epiphysis in Connecticut and Southwestern United States. J Bone Joint Surg 1970; 52A:1203-1216.
40. Crawford A, MacEwen G, Fonte D: Slipped capital femoral epiphysis coexistent with hypothyroidism. Clin Orthop 1977; 122: 135-139.
41. Kelsey J: The epidemiology of diseases of the hip: a review. Int J Epidemiol 1977; 6: 269-280.
42. Puri R, Smith C, Mathofra D, Williams A, Owen R, Harris F: Slipped capital femoral epiphysis and primary juvenile hypothyroidism. J Bone Joint Surg (Br) 1985; 67: 14-20.
43. Fidler MW, Brook CGD: Slipped upper femoral epiphysis following treatment with human growth hormone. J Bone Joint Surg 1974; 56: 1719-1722.
44. Heatley FW, Greenwood RH, Boase DL: Slipping of the upper femoral epiphyses in patients with intracranial tumours causing hypopituitarism and chiasmal compression. J Bone Joint Surg 1976; 58B:169-175.
45. Rennie W, Mitchell N: Slipped femoral capital epiphysis occurring during growth hormone therapy. J Bone Joint Surg 1974; 56: 703-705.
46. Prasad V, Greig F, Bastian W, Castells S, Juan C, AvRuskin TW: Slipped capital femoral epiphysis during treatment with recombinant growth hormone for isolated, partial growth hormone deficiency. J Pediatr 1990; 116: 397-399.
47. Rappaport EB, Fife D: Slipped capital femoral epiphysis in growth hormonedeficient patients. Am J Dis Child 1985; 139: 396-399.
48. Blethen SL, Rundle AC: Slipped capital femoral epiphysis in children treated with growth hormone. Horm Res 1996; 46: 113-116.
49. Van den Berg BJ, Yerushelmy J: Studies on convulsive disorders in young children. 1. Incidence of febrile and nonfebrile convulsions by age and other factors. Pediatr Res 1969; 3: 298-304.
50. Heijbel J, Blom S, Bergfors PG: Benign epilepsy of children with centro-temporal foci: a study of incidence rate in out-patient care. Epilepsia 1975; 65: 657-664.
51. Shamansky SL, Glaser GH: Socioeconomic characteristics of childhood seizure disorders in the New Haven area: an epidemiological study. Epilepsia 1979; 20: 457-474.
52. Doose H, Sitepu B: Childhood epilepsy in a German city. Neuropediatrics 1983; 14: 220-224.
53. Sidenvall R, Forsgren L, Blomqvist HK, Heijbel J: A community-based prospective incidence study of epileptic seizures in children. Acta Paediatr Scand 1993; 82: 60-65.
54. Raimondi A, Tomita T: Medulloblastoma in childhood. Childs Brain 1979; 5: 310-328.
55. Yssing M, Garwiezs S, Glomstein A, Jonmundsson G, Kruus S: Medulloblastoma in Nordic children. 2. Acta Paediatr Scand Suppl 1990; 371: 12-19.